Vietnam

Hanoi Medical University (HMU)

HMU offers training focused on HIV/AIDS, STIs, antimicrobial resistance, substance use and mental health.

HMU is the oldest and largest health sciences university in Vietnam. HMU has a 400-bed general hospital and a number of schools in medicine, nursing, public health and traditional medicine. HMU faculty are collaborating on several National Institutes of Health (NIH)-funded studies. Along with US-based investigators, HMU's Center for Training and Research on Substance Abuse-HIV (CREATA-H) has developed expertise in addiction and HIV research and clinical care for men who have sex with men and injection drug users. In addition to collaborating with US researchers, HMU faculty members are collaborating with researchers from Australia, Japan, Sweden, Denmark, UK, France and many other countries. Based on these collaborative efforts, faculty members have mentored many postdoctoral students from both within and beyond Vietnam.

Since 2013, the School for Preventive Medicine and Public Health has led a President's Emergency Plan for AIDS Relief (PEPFAR)-funded Cooperative Agreement with the Centers for Disease Control to support capacity building for program evaluation on public health and HIV/AIDS. Since 2011, also with support from PEPFAR and the Substance Abuse and Mental Health Services Administration, HMU has partnered with UCLA's Drs. Rawson and Larkin to create the Vietnam-HIV Addiction Technology Transfer Center, which is building human resources for addiction treatment in Vietnam.

In 2016, HMU began a new partnership with UCLA through a Fogarty-funded D43 training program on advanced epidemiological methods for Vietnamese scholars led by Dr L. Li (UCLA). In 2017, HMU began an ongoing collaboration with UCLA (Dr. Klausner) in the study of antimicrobial resistance in sexually transmitted diseases and laboratory work on the study of mechanisms of resistance. In 2020, HMU was funded by NIDA to collaborate with UCLA (Dr. Shoptaw) on a study to reduce methamphetamine use among people with opioid use disorders who are on methadone treatment.

Site contact: Dr. Le Minh Giang